Table 2 Whole cohort glycemic control results
From: Second pilot trials of the STAR-Liege protocol for tight glycemic control in critically ill patients
SL2 clinical data | SL1 clinical data | p-value | |||
|---|---|---|---|---|---|
Pre 24 hour | Pilot trial (+) | Post 24 hour | Pilot trial (+) | SL1 vs. SL2 | |
Number of patients: | 9 | 9 | 9 | 9 | / |
Total hours: | / | 194 h | / | 215 h | / |
Number of BG measurements: | 46 | 91 | 44 | 205 | / |
BG median [IQR] (mg/dL): | 155.5 [124.0 - 171.0] | 134.0 [117.2 - 150.8] | 136.5 [115.0 - 159.5] | 136.0 [122.5 - 158.0] | 0.27(*) |
% BG within 80–100 mg/dL | 8.7 | 3.3 | 6.82 | 3.4 | 1.00 |
% BG within 100–140 mg/dL | 10.9 | 54.9 | 43.18 | 50.7 | 0.53 |
% BG within 140–180 mg/dL | 50.0 | 33.0 | 36.36 | 37.1 | 0.51 |
% BG ≥ 180 mg/dL | 19.6 | 7.7 | 9.09 | 8.3 | 1.00 |
% BG < 90 mg/dL | 19.6 | 3.3 | 11.4 | 2.0 | 0.44 |
% BG < 80 mg/dL | 10.9 | 1.1 | 4.55 | 0.5 | 0.52 |
% BG < 40 mg/dL | 0.0 | 0.0 | 0.0 | 0.0 | 1.00 |
Number of patients < 40 mg/dL | 0 | 0 | 0 | 0 | / |
Median insulin rate [IQR] (U/h): | / | 2.0 [1.0 - 2.5] | / | 1.5 [0.5 - 3.4] | 0.92(*) |
Median glucose rate [IQR] (g/h): | / | 0.0 [0.0 - 5.4] | / | 7.4 [2.0 - 11.2] | 0.00(*) |